ticker
stringlengths 1
10
| date
timestamp[ns] | client
stringlengths 1
80
| client_description
stringlengths 2
114
⌀ | spend
float64 0
25.9M
| transaction_type
stringclasses 7
values | filing_type
stringclasses 7
values | lobby_description
sequencelengths 0
34
| issue_codes
sequencelengths 1
34
⌀ | government_entity_details
sequencelengths 1
725
⌀ | quarter
stringclasses 66
values | effective_date
stringlengths 10
10
| termination_date
stringlengths 10
10
⌀ | client_state
stringclasses 56
values | client_country
stringclasses 40
values | client_id
int64 12
10M
| government_lobby
float64 0
1
⌀ | performing_own_lobbying
float64 0
1
⌀ | registrant_dt_updated
stringlengths 32
32
| registrant_name
stringlengths 3
99
| registrant_address
stringlengths 32
87
| registrant_id
int64 33
401M
| registrant_description
stringlengths 2
103
⌀ | registrant_contact_name
stringlengths 0
34
| registrant_house_registrant_id
float64 12.7k
401M
⌀ | registrant_contact_telephone
stringlengths 0
16
| lobbyist_full_names
sequencelengths 1
272
⌀ | lobbyist_ids
sequencelengths 1
272
⌀ | previous_goverment_positions
sequencelengths 1
272
⌀ | lobbyist_new_statuses
sequencelengths 1
272
⌀ | client_url
stringlengths 44
45
| registrant_url
stringlengths 45
52
| filing_url
stringlengths 88
88
| filing_id
stringlengths 36
36
| unique_id
stringlengths 46
53
| match
stringlengths 1
80
| date_time
timestamp[ns] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZYNE | 2016-10-20T00:00:00 | zynerba pharmaceuticals | Pharmaceutical and therapeutic company. | 20,000 | lobbying_income | service_provided | [
"H.R. 5293 / S. 3000 - Department of Defense Appropriations Bill, 2017; seek support for PTSD treatment."
] | [
"BUD - Budget/Appropriations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2016-Q3 | 2016-03-10 | null | PA | US | 202 | 0 | null | 2024-01-30T15:42:30.112656-05:00 | THE CONAFAY GROUP, LLC | 1001 Pennsylvania Ave, NW, 13th Floor North, Washington, DC, 20004, US | 401,004,840 | Life Sciences Consulting Firm | ERICA WOODWARD | 401,004,840 | +1 859-229-7237 | [
"JULIE P. PAWELCZYK"
] | [
64541
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/196754/ | https://lda.senate.gov/api/v1/registrants/401004840/ | https://lda.senate.gov/filings/public/filing/762e7a69-5af6-4583-98ea-884a8774945d/print/ | 762e7a69-5af6-4583-98ea-884a8774945d | 762e7a69-5af6-4583-98ea-884a8774945d_401004840_196754 | zynerba pharmaceuticals | 2016-10-20T20:33:18 |
ZYNE | 2017-04-19T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | retainer | [] | null | null | 2017-Q1 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | null | null | null | null | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/cc1dcb9f-2ed8-40eb-a33a-19428036732e/print/ | cc1dcb9f-2ed8-40eb-a33a-19428036732e | cc1dcb9f-2ed8-40eb-a33a-19428036732e_55291_159682 | zynerba pharmaceuticals, inc. | 2017-04-19T19:46:36 |
ZYNE | 2017-04-20T00:00:00 | zynerba pharmaceuticals | Pharmaceutical and therapeutic company. | 5,000 | lobbying_income | terminate_retainer | [] | null | null | 2017-Q1 | 2016-03-10 | 2017-01-16 | PA | US | 202 | 0 | null | 2024-01-30T15:42:30.112656-05:00 | THE CONAFAY GROUP, LLC | 1001 Pennsylvania Ave, NW, 13th Floor North, Washington, DC, 20004, US | 401,004,840 | Life Sciences Consulting Firm | ERICA WOODWARD | 401,004,840 | +1 859-229-7237 | null | null | null | null | https://lda.senate.gov/api/v1/clients/196754/ | https://lda.senate.gov/api/v1/registrants/401004840/ | https://lda.senate.gov/filings/public/filing/8a99e99a-6752-48bc-93db-e6296ccbb598/print/ | 8a99e99a-6752-48bc-93db-e6296ccbb598 | 8a99e99a-6752-48bc-93db-e6296ccbb598_401004840_196754 | zynerba pharmaceuticals | 2017-04-20T17:52:54 |
ZYNE | 2017-07-19T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | retainer | [] | null | null | 2017-Q2 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | null | null | null | null | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/c71d941d-8387-4ac5-9abc-d9f731737ef4/print/ | c71d941d-8387-4ac5-9abc-d9f731737ef4 | c71d941d-8387-4ac5-9abc-d9f731737ef4_55291_159682 | zynerba pharmaceuticals, inc. | 2017-07-19T15:01:07 |
ZYNE | 2017-10-19T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | retainer | [] | null | null | 2017-Q3 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | null | null | null | null | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/2739e695-6682-4838-a905-fc19cb7b43dd/print/ | 2739e695-6682-4838-a905-fc19cb7b43dd | 2739e695-6682-4838-a905-fc19cb7b43dd_55291_159682 | zynerba pharmaceuticals, inc. | 2017-10-19T16:01:43 |
ZYNE | 2018-01-19T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | retainer | [] | null | null | 2017-Q4 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | null | null | null | null | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/6c7e8e1f-b867-4c0e-9963-c5f33cfeee4c/print/ | 6c7e8e1f-b867-4c0e-9963-c5f33cfeee4c | 6c7e8e1f-b867-4c0e-9963-c5f33cfeee4c_55291_159682 | zynerba pharmaceuticals, inc. | 2018-01-19T19:35:40 |
ZYNE | 2018-04-20T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | retainer | [] | null | null | 2018-Q1 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | null | null | null | null | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/32706449-179d-4944-8663-0355b69a9357/print/ | 32706449-179d-4944-8663-0355b69a9357 | 32706449-179d-4944-8663-0355b69a9357_55291_159682 | zynerba pharmaceuticals, inc. | 2018-04-20T08:51:54 |
ZYNE | 2018-07-19T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | retainer | [] | null | null | 2018-Q2 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | null | null | null | null | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/e50c2340-067b-4aa1-ab34-84708640dc8f/print/ | e50c2340-067b-4aa1-ab34-84708640dc8f | e50c2340-067b-4aa1-ab34-84708640dc8f_55291_159682 | zynerba pharmaceuticals, inc. | 2018-07-19T10:16:20 |
ZYNE | 2018-10-22T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 10,000 | lobbying_income | service_provided | [
"DEA Approval of clinical studies",
"DEA Approval of clinical studies"
] | [
"PHA - Pharmacy",
"MED - Medical/Disease Research/Clinical Labs"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q3 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/e729ad86-6159-4113-b3e1-4acb99376cab/print/ | e729ad86-6159-4113-b3e1-4acb99376cab | e729ad86-6159-4113-b3e1-4acb99376cab_55291_159682 | zynerba pharmaceuticals, inc. | 2018-10-22T14:41:48 |
ZYNE | 2019-01-17T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | service_provided | [
"DEA Approval of clinical studies",
"DEA Approval of clinical studies"
] | [
"PHA - Pharmacy",
"MED - Medical/Disease Research/Clinical Labs"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q4 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/a5e6c108-c8a0-4f7a-97fc-7edc4cf92e78/print/ | a5e6c108-c8a0-4f7a-97fc-7edc4cf92e78 | a5e6c108-c8a0-4f7a-97fc-7edc4cf92e78_55291_159682 | zynerba pharmaceuticals, inc. | 2019-01-17T20:41:59 |
ZYNE | 2019-04-22T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | service_provided | [
"Raise awareness of synthetic CBD for research and hemp legislation",
"Raise awareness of synthetic CBD for research and hemp legislation"
] | [
"PHA - Pharmacy",
"MED - Medical/Disease Research/Clinical Labs"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q1 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/6caca8a6-dd11-49c9-8237-c40bce11ffc1/print/ | 6caca8a6-dd11-49c9-8237-c40bce11ffc1 | 6caca8a6-dd11-49c9-8237-c40bce11ffc1_55291_159682 | zynerba pharmaceuticals, inc. | 2019-04-22T17:39:05 |
ZYNE | 2019-07-19T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | service_provided | [
"Raise awareness of synthetic CBD for research and hemp legislation",
"Raise awareness of synthetic CBD for research and hemp legislation; Advocate for inclusion of synthetic CBD in Farm Bill or other legislation"
] | [
"PHA - Pharmacy",
"MED - Medical/Disease Research/Clinical Labs"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q2 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/4ab8b91f-8066-4de4-b9e7-3eb786a1ca85/print/ | 4ab8b91f-8066-4de4-b9e7-3eb786a1ca85 | 4ab8b91f-8066-4de4-b9e7-3eb786a1ca85_55291_159682 | zynerba pharmaceuticals, inc. | 2019-07-19T16:26:15 |
ZYNE | 2019-10-21T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | service_provided | [
"Raise awareness of synthetic CBD for research and hemp legislation",
"Raise awareness of synthetic CBD for research and hemp legislation; Advocate for inclusion of synthetic CBD in Farm Bill or other legislation"
] | [
"PHA - Pharmacy",
"MED - Medical/Disease Research/Clinical Labs"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q3 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/441e1e76-bbd9-46d7-99f0-743c24b2f26c/print/ | 441e1e76-bbd9-46d7-99f0-743c24b2f26c | 441e1e76-bbd9-46d7-99f0-743c24b2f26c_55291_159682 | zynerba pharmaceuticals, inc. | 2019-10-21T19:15:01 |
ZYNE | 2020-01-21T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | service_provided | [
"Raise awareness of synthetic CBD for research and hemp legislation",
"Raise awareness of synthetic CBD for research and hemp legislation; Advocate for inclusion of synthetic CBD in Farm Bill or other legislation"
] | [
"PHA - Pharmacy",
"MED - Medical/Disease Research/Clinical Labs"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q4 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/06c98791-3159-4870-8a16-a53a185e8ba9/print/ | 06c98791-3159-4870-8a16-a53a185e8ba9 | 06c98791-3159-4870-8a16-a53a185e8ba9_55291_159682 | zynerba pharmaceuticals, inc. | 2020-01-21T15:28:11 |
ZYNE | 2020-04-19T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | service_provided | [
"Raise awareness of synthetic CBD for research and hemp legislation",
"Raise awareness of synthetic CBD for research and hemp legislation; Advocate for inclusion of synthetic CBD in Farm Bill or other legislation"
] | [
"PHA - Pharmacy",
"MED - Medical/Disease Research/Clinical Labs"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q1 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/5600f156-b5c3-4c68-9f78-1c297d286576/print/ | 5600f156-b5c3-4c68-9f78-1c297d286576 | 5600f156-b5c3-4c68-9f78-1c297d286576_55291_159682 | zynerba pharmaceuticals, inc. | 2020-04-19T13:00:16 |
ZYNE | 2020-07-20T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | service_provided | [
"Raise awareness of synthetic CBD for research and hemp legislation",
"Raise awareness of synthetic CBD for research and hemp legislation; Advocate for inclusion of synthetic CBD in Farm Bill or other legislation"
] | [
"PHA - Pharmacy",
"MED - Medical/Disease Research/Clinical Labs"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q2 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/8ca50f3f-72c2-432e-b0cc-351866cc2c2e/print/ | 8ca50f3f-72c2-432e-b0cc-351866cc2c2e | 8ca50f3f-72c2-432e-b0cc-351866cc2c2e_55291_159682 | zynerba pharmaceuticals, inc. | 2020-07-20T12:31:19 |
ZYNE | 2020-10-05T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 5,000 | lobbying_income | service_provided | [
"Brief key House & Senate Members and/or appropriate staff on need and justification for this product. Secure letter of support for applications from key House & Senate Members.",
"Assist in the development & approval process before the FDA of Zynerba's lead therapeutic for the potential treatment of behavioral symptoms associated with Fragile X Syndrome.",
"Support Zynerba and its partners, and any other of its contractors in its process before the FDA; Troubleshoot inevitable issues and eligibility hurdles to ensure the project is considered for approval; Brief staff of FDA throughout process to ensure they have all information needed; Work with Zynerba to formulate the best strategy to work with FDA in preparation for any scheduled meetings."
] | [
"GOV - Government Issues",
"HCR - Health Issues",
"PHA - Pharmacy"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q3 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/12c11c87-aa4b-4691-95fb-80172ab11942/print/ | 12c11c87-aa4b-4691-95fb-80172ab11942 | 12c11c87-aa4b-4691-95fb-80172ab11942_401104403_206871 | zynerba pharmaceuticals, inc. | 2020-10-05T17:28:00 |
ZYNE | 2020-10-20T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | service_provided | [
"Raise awareness of synthetic CBD for research and hemp legislation",
"Raise awareness of synthetic CBD for research and hemp legislation; Advocate for inclusion of synthetic CBD in Farm Bill or other legislation"
] | [
"PHA - Pharmacy",
"MED - Medical/Disease Research/Clinical Labs"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q3 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/69c4b07f-428d-484c-b4e2-de7b2cf1bb50/print/ | 69c4b07f-428d-484c-b4e2-de7b2cf1bb50 | 69c4b07f-428d-484c-b4e2-de7b2cf1bb50_55291_159682 | zynerba pharmaceuticals, inc. | 2020-10-21T01:22:12 |
ZYNE | 2021-01-08T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 45,000 | lobbying_income | service_provided | [
"Brief key House & Senate Members and/or appropriate staff on need and justification for this product. Secure letter of support for applications from key House & Senate Members.",
"Assist in the development & approval process before the FDA of Zynerba's lead therapeutic for the potential treatment of behavioral symptoms associated with Fragile X Syndrome.",
"Support Zynerba and its partners, and any other of its contractors in its process before the FDA; Troubleshoot inevitable issues and eligibility hurdles to ensure the project is considered for approval; Brief staff of FDA throughout process to ensure they have all information needed; Work with Zynerba to formulate the best strategy to work with FDA in preparation for any scheduled meetings."
] | [
"GOV - Government Issues",
"HCR - Health Issues",
"PHA - Pharmacy"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/3adf3d37-e174-45d7-94ad-4f77ef388494/print/ | 3adf3d37-e174-45d7-94ad-4f77ef388494 | 3adf3d37-e174-45d7-94ad-4f77ef388494_401104403_206871 | zynerba pharmaceuticals, inc. | 2021-01-08T17:24:00 |
ZYNE | 2021-01-21T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | service_provided | [
"Raise awareness of synthetic CBD for research and hemp legislation; Advocate for inclusion of synthetic CBD in Farm Bill or other legislation",
"Raise awareness of synthetic CBD for research and hemp legislation"
] | [
"MED - Medical/Disease Research/Clinical Labs",
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | [
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK",
"MICHAEL P STRAZZELLA",
"EDWARD JOHN ALLERA",
"ELIZABETH WESTBROOK"
] | [
58343,
43567,
61183,
58343,
43567,
61183
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/1a946d6a-6cc0-4f5d-baad-aa334418a4cc/print/ | 1a946d6a-6cc0-4f5d-baad-aa334418a4cc | 1a946d6a-6cc0-4f5d-baad-aa334418a4cc_55291_159682 | zynerba pharmaceuticals, inc. | 2021-01-21T22:39:22 |
ZYNE | 2021-04-19T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | retainer | [] | null | null | 2021-Q1 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | null | null | null | null | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/8aaea0ff-d784-4b21-8c37-dacdb51244b4/print/ | 8aaea0ff-d784-4b21-8c37-dacdb51244b4 | 8aaea0ff-d784-4b21-8c37-dacdb51244b4_55291_159682 | zynerba pharmaceuticals, inc. | 2021-04-19T13:55:55 |
ZYNE | 2021-04-19T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 45,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction",
"Set up meetings or calls with Members for Zynerba when necessary;",
"Providing services on behalf of Zynerba to the pharmaceutical industry"
] | [
"HCR - Health Issues",
"GOV - Government Issues",
"PHA - Pharmacy"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q1 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/7ef09c24-9b5e-4360-b8b6-f9c47ffc9085/print/ | 7ef09c24-9b5e-4360-b8b6-f9c47ffc9085 | 7ef09c24-9b5e-4360-b8b6-f9c47ffc9085_401104403_206871 | zynerba pharmaceuticals, inc. | 2021-04-20T01:11:43 |
ZYNE | 2021-07-08T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 45,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction",
"Set up meetings or calls with Members for Zynerba when necessary;",
"Providing services on behalf of Zynerba to the pharmaceutical industry"
] | [
"HCR - Health Issues",
"GOV - Government Issues",
"PHA - Pharmacy"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q2 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/4fae6076-de3c-40f0-b42c-b762bb5ed069/print/ | 4fae6076-de3c-40f0-b42c-b762bb5ed069 | 4fae6076-de3c-40f0-b42c-b762bb5ed069_401104403_206871 | zynerba pharmaceuticals, inc. | 2021-07-08T15:18:35 |
ZYNE | 2021-07-10T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | retainer | [] | null | null | 2021-Q2 | 2015-02-01 | null | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | null | null | null | null | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/581b9e37-0dcc-4072-bcd0-3162c242c91b/print/ | 581b9e37-0dcc-4072-bcd0-3162c242c91b | 581b9e37-0dcc-4072-bcd0-3162c242c91b_55291_159682 | zynerba pharmaceuticals, inc. | 2021-07-10T11:32:09 |
ZYNE | 2021-10-18T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 45,000 | lobbying_income | service_provided | [
"Providing services on behalf of Zynerba to the pharmaceutical industry",
"Encourage Members to act favorably on matters of importance to Zynerba at their direction",
"Set up meetings or calls with Members for Zynerba when necessary;"
] | [
"PHA - Pharmacy",
"HCR - Health Issues",
"GOV - Government Issues"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q3 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/98120117-54e1-4674-9044-931ce97af690/print/ | 98120117-54e1-4674-9044-931ce97af690 | 98120117-54e1-4674-9044-931ce97af690_401104403_206871 | zynerba pharmaceuticals, inc. | 2021-10-18T14:59:21 |
ZYNE | 2021-10-19T00:00:00 | zynerba pharmaceuticals, inc. | pharmaceutical | 5,000 | lobbying_income | terminate_retainer | [] | null | null | 2021-Q3 | 2015-02-01 | 2021-09-30 | PA | US | 1,005,317 | 0 | null | 2024-01-30T10:47:25.465555-05:00 | BUCHANAN INGERSOLL & ROONEY PC | 1700 K Street, NW, Suite 300, Washington, DC, 20006, US | 55,291 | law firm | WILL LE | 35,132 | +1 202-452-5783 | null | null | null | null | https://lda.senate.gov/api/v1/clients/159682/ | https://lda.senate.gov/api/v1/registrants/55291/ | https://lda.senate.gov/filings/public/filing/1553fad8-bdff-4bcc-8efd-a1917847b798/print/ | 1553fad8-bdff-4bcc-8efd-a1917847b798 | 1553fad8-bdff-4bcc-8efd-a1917847b798_55291_159682 | zynerba pharmaceuticals, inc. | 2021-10-19T14:48:17 |
ZYNE | 2022-01-10T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 30,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction",
"Set up meetings or calls with Members for Zynerba when necessary; Help in identifying Testing Sites",
"Providing services on behalf of Zynerba to the pharmaceutical industry - looking for testing sites"
] | [
"HCR - Health Issues",
"GOV - Government Issues",
"PHA - Pharmacy"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q4 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/3901f634-6ea2-4557-bf35-9f7fdc505fb9/print/ | 3901f634-6ea2-4557-bf35-9f7fdc505fb9 | 3901f634-6ea2-4557-bf35-9f7fdc505fb9_401104403_206871 | zynerba pharmaceuticals, inc. | 2022-01-10T16:45:08 |
ZYNE | 2022-04-19T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 30,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction",
"Set up meetings or calls with Members for Zynerba when necessary; Help in identifying Testing Sites",
"Providing services on behalf of Zynerba to the pharmaceutical industry - looking for testing sites"
] | [
"HCR - Health Issues",
"GOV - Government Issues",
"PHA - Pharmacy"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2022-Q1 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/950235cc-780a-4d25-9b25-a1c453b32d73/print/ | 950235cc-780a-4d25-9b25-a1c453b32d73 | 950235cc-780a-4d25-9b25-a1c453b32d73_401104403_206871 | zynerba pharmaceuticals, inc. | 2022-04-19T14:31:47 |
ZYNE | 2022-07-13T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 20,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; trial for medication that could help individuals with fragile x syndrome.",
"Set up meetings or calls with Members for Zynerba when necessary; Help in identifying Testing Sites; working with UMMC physicians on the trail study.",
"Providing services on behalf of Zynerba to the pharmaceutical industry - looking for testing sites"
] | [
"HCR - Health Issues",
"GOV - Government Issues",
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2022-Q2 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/700bf9e7-7990-409d-9bef-e8f341f1c15f/print/ | 700bf9e7-7990-409d-9bef-e8f341f1c15f | 700bf9e7-7990-409d-9bef-e8f341f1c15f_401104403_206871 | zynerba pharmaceuticals, inc. | 2022-07-14T00:29:39 |
ZYNE | 2022-10-12T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 15,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; trial for medication that could help individuals with fragile x syndrome.",
"Set up meetings or calls with Members for Zynerba when necessary; Help in identifying Testing Sites; working with UMMC physicians on the trail study.",
"Providing services on behalf of Zynerba to the pharmaceutical industry - looking for testing sites"
] | [
"HCR - Health Issues",
"GOV - Government Issues",
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2022-Q3 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/65b54951-9914-4218-8487-0401afd05d4b/print/ | 65b54951-9914-4218-8487-0401afd05d4b | 65b54951-9914-4218-8487-0401afd05d4b_401104403_206871 | zynerba pharmaceuticals, inc. | 2022-10-12T15:19:42 |
ZYNE | 2023-01-09T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 15,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; trial for medication that could help individuals with fragile x syndrome.",
"Set up meetings or calls with Members for Zynerba when necessary; Help in identifying Testing Sites; working with UMMC physicians on the trail study.",
"Providing services on behalf of Zynerba to the pharmaceutical industry - looking for testing sites"
] | [
"HCR - Health Issues",
"GOV - Government Issues",
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2022-Q4 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/fc59f449-d707-44ef-99b1-f66dc8f92d74/print/ | fc59f449-d707-44ef-99b1-f66dc8f92d74 | fc59f449-d707-44ef-99b1-f66dc8f92d74_401104403_206871 | zynerba pharmaceuticals, inc. | 2023-01-09T16:36:49 |
ZYNE | 2023-04-05T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 15,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.",
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.",
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome."
] | [
"PHA - Pharmacy",
"GOV - Government Issues",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2023-Q1 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/672115f8-d2e2-48d6-94e4-a4aacb87926b/print/ | 672115f8-d2e2-48d6-94e4-a4aacb87926b | 672115f8-d2e2-48d6-94e4-a4aacb87926b_401104403_206871 | zynerba pharmaceuticals, inc. | 2023-04-05T15:19:18 |
ZYNE | 2023-07-18T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 45,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.",
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.",
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome."
] | [
"PHA - Pharmacy",
"GOV - Government Issues",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2023-Q2 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/61d4f7d6-e612-410d-a2a7-9a3258b99a3c/print/ | 61d4f7d6-e612-410d-a2a7-9a3258b99a3c | 61d4f7d6-e612-410d-a2a7-9a3258b99a3c_401104403_206871 | zynerba pharmaceuticals, inc. | 2023-07-18T15:00:12 |
ZYNE | 2023-10-04T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 45,000 | lobbying_income | service_provided | [
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.",
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.",
"Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome."
] | [
"PHA - Pharmacy",
"GOV - Government Issues",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2023-Q3 | 2020-09-15 | null | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | [
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)",
"GREGG L HARPER (Former Member of U.S. House of Representatives)"
] | [
79398,
79398,
79398
] | [
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives",
"Former Member of U.S. House of Representatives"
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/b915aaef-b8fc-42dc-bebf-12f93c1b2adf/print/ | b915aaef-b8fc-42dc-bebf-12f93c1b2adf | b915aaef-b8fc-42dc-bebf-12f93c1b2adf_401104403_206871 | zynerba pharmaceuticals, inc. | 2023-10-04T15:16:34 |
ZYNE | 2024-01-08T00:00:00 | zynerba pharmaceuticals, inc. | health/governmental assistance before FDA | 5,000 | lobbying_income | terminate_retainer | [] | null | null | 2023-Q4 | 2020-09-15 | 2023-10-15 | PA | US | 101 | 0 | null | 2024-01-08T13:14:37.793087-05:00 | WATKINS & EAGER PLLC | 400 East Capitol Street, Jackson, MS, 39201, US | 401,104,403 | law firm | GREGG HARPER | 401,104,403 | +1 601-291-6839 | null | null | null | null | https://lda.senate.gov/api/v1/clients/206871/ | https://lda.senate.gov/api/v1/registrants/401104403/ | https://lda.senate.gov/filings/public/filing/f0e8ac3c-c982-44a2-8c96-6d8b62a830a3/print/ | f0e8ac3c-c982-44a2-8c96-6d8b62a830a3 | f0e8ac3c-c982-44a2-8c96-6d8b62a830a3_401104403_206871 | zynerba pharmaceuticals, inc. | 2024-01-08T17:10:04 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.